
Gary Jackson
Supervisory Patent Examiner (ID: 5661, Phone: (571)272-4697 , Office: P/3769 )
| Most Active Art Unit | 3731 |
| Art Unit(s) | 3304, 3308, 4158, 3727, 3309, 2899, 3734, 3792, 3731, 3407, 3769 |
| Total Applications | 2094 |
| Issued Applications | 1632 |
| Pending Applications | 166 |
| Abandoned Applications | 295 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 463554
[patent_doc_number] => 07238660
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-03
[patent_title] => 'Albumin fusion proteins'
[patent_app_type] => utility
[patent_app_number] => 11/393893
[patent_app_country] => US
[patent_app_date] => 2006-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 179602
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/238/07238660.pdf
[firstpage_image] =>[orig_patent_app_number] => 11393893
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/393893 | Albumin fusion proteins | Mar 30, 2006 | Issued |
Array
(
[id] => 5700055
[patent_doc_number] => 20060216739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Insulin-like growth factor binding protein'
[patent_app_type] => utility
[patent_app_number] => 11/396430
[patent_app_country] => US
[patent_app_date] => 2006-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 34967
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20060216739.pdf
[firstpage_image] =>[orig_patent_app_number] => 11396430
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/396430 | Insulin-like growth factor binding protein | Mar 29, 2006 | Issued |
Array
(
[id] => 5625870
[patent_doc_number] => 20060264375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Elastin protective polyphenolics and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 11/394354
[patent_app_country] => US
[patent_app_date] => 2006-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10901
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20060264375.pdf
[firstpage_image] =>[orig_patent_app_number] => 11394354
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/394354 | Elastin protective polyphenolics and methods of using the same | Mar 28, 2006 | Issued |
Array
(
[id] => 5760675
[patent_doc_number] => 20060211620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Polypeptides having antimicrobial activity and polynucleotides encoding same'
[patent_app_type] => utility
[patent_app_number] => 11/384643
[patent_app_country] => US
[patent_app_date] => 2006-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25498
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20060211620.pdf
[firstpage_image] =>[orig_patent_app_number] => 11384643
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/384643 | Polypeptides having antimicrobial activity and polynucleotides encoding same | Mar 19, 2006 | Issued |
Array
(
[id] => 326629
[patent_doc_number] => 07514400
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-07
[patent_title] => 'Synthetic mimics of mammalian cell surface receptors: method and compositions'
[patent_app_type] => utility
[patent_app_number] => 11/368661
[patent_app_country] => US
[patent_app_date] => 2006-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 38575
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/514/07514400.pdf
[firstpage_image] =>[orig_patent_app_number] => 11368661
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/368661 | Synthetic mimics of mammalian cell surface receptors: method and compositions | Mar 5, 2006 | Issued |
Array
(
[id] => 4608593
[patent_doc_number] => 07993848
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-09
[patent_title] => 'Staphylococcus protein A domain mutants that bind to TNF-α'
[patent_app_type] => utility
[patent_app_number] => 11/885373
[patent_app_country] => US
[patent_app_date] => 2006-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 11778
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/993/07993848.pdf
[firstpage_image] =>[orig_patent_app_number] => 11885373
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/885373 | Staphylococcus protein A domain mutants that bind to TNF-α | Feb 28, 2006 | Issued |
Array
(
[id] => 875931
[patent_doc_number] => 07358085
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-15
[patent_title] => 'Anti-angiogenic methods and compositions'
[patent_app_type] => utility
[patent_app_number] => 11/365390
[patent_app_country] => US
[patent_app_date] => 2006-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 26614
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/358/07358085.pdf
[firstpage_image] =>[orig_patent_app_number] => 11365390
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/365390 | Anti-angiogenic methods and compositions | Feb 27, 2006 | Issued |
Array
(
[id] => 5336847
[patent_doc_number] => 20090053311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'Pharmaceutical Compositions for Treating or Preventing Bone Conditions'
[patent_app_type] => utility
[patent_app_number] => 11/884525
[patent_app_country] => US
[patent_app_date] => 2006-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 21589
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20090053311.pdf
[firstpage_image] =>[orig_patent_app_number] => 11884525
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/884525 | Pharmaceutical compositions for treating or preventing bone conditions | Feb 15, 2006 | Issued |
Array
(
[id] => 909937
[patent_doc_number] => 07329541
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-12
[patent_title] => 'Zinc finger binding domains for GNN'
[patent_app_type] => utility
[patent_app_number] => 11/351561
[patent_app_country] => US
[patent_app_date] => 2006-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 2
[patent_no_of_words] => 17862
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/329/07329541.pdf
[firstpage_image] =>[orig_patent_app_number] => 11351561
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/351561 | Zinc finger binding domains for GNN | Feb 9, 2006 | Issued |
Array
(
[id] => 5585461
[patent_doc_number] => 20090104663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Novel Hydrophobin Fusion Products, Production and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/883778
[patent_app_country] => US
[patent_app_date] => 2006-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6221
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20090104663.pdf
[firstpage_image] =>[orig_patent_app_number] => 11883778
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/883778 | Hydrophobin fusion products, production and use thereof | Feb 6, 2006 | Issued |
Array
(
[id] => 359740
[patent_doc_number] => 07485619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-03
[patent_title] => 'Antimicrobial agent'
[patent_app_type] => utility
[patent_app_number] => 11/307316
[patent_app_country] => US
[patent_app_date] => 2006-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19363
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/485/07485619.pdf
[firstpage_image] =>[orig_patent_app_number] => 11307316
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/307316 | Antimicrobial agent | Jan 30, 2006 | Issued |
Array
(
[id] => 5700099
[patent_doc_number] => 20060216783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Polypeptide factor from a thermophilic eubacterial species and use thereof in the production of functional, heterologous proteins in an expression host'
[patent_app_type] => utility
[patent_app_number] => 11/322333
[patent_app_country] => US
[patent_app_date] => 2006-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7089
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20060216783.pdf
[firstpage_image] =>[orig_patent_app_number] => 11322333
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/322333 | Polypeptide factor from a thermophilic eubacterial species and use thereof in the production of functional, heterologous proteins in an expression host | Jan 2, 2006 | Abandoned |
Array
(
[id] => 5429054
[patent_doc_number] => 20090088364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-02
[patent_title] => 'Pharmaceutical composition useful for the treatment of invasive pulmonary aspergillosis'
[patent_app_type] => utility
[patent_app_number] => 10/570695
[patent_app_country] => US
[patent_app_date] => 2005-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6121
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20090088364.pdf
[firstpage_image] =>[orig_patent_app_number] => 10570695
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/570695 | Pharmaceutical composition useful for the treatment of invasive pulmonary aspergillosis | Dec 21, 2005 | Abandoned |
Array
(
[id] => 4915219
[patent_doc_number] => 20080095819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'Composition and Methods for Promoting Wound Healing and tissue Regeneration'
[patent_app_type] => utility
[patent_app_number] => 11/721529
[patent_app_country] => US
[patent_app_date] => 2005-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 29281
[patent_no_of_claims] => 74
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20080095819.pdf
[firstpage_image] =>[orig_patent_app_number] => 11721529
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/721529 | Composition and methods for promoting wound healing and tissue regeneration | Dec 19, 2005 | Issued |
Array
(
[id] => 498692
[patent_doc_number] => 07208656
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-24
[patent_title] => 'Nucleotide sequences encoding anthonomous toxic polypeptides from Bacillus thuringiensis '
[patent_app_type] => utility
[patent_app_number] => 11/302357
[patent_app_country] => US
[patent_app_date] => 2005-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 29026
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/208/07208656.pdf
[firstpage_image] =>[orig_patent_app_number] => 11302357
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/302357 | Nucleotide sequences encoding anthonomous toxic polypeptides from Bacillus thuringiensis | Dec 12, 2005 | Issued |
Array
(
[id] => 5630927
[patent_doc_number] => 20060147395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Protein formulation'
[patent_app_type] => utility
[patent_app_number] => 11/301123
[patent_app_country] => US
[patent_app_date] => 2005-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 24485
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20060147395.pdf
[firstpage_image] =>[orig_patent_app_number] => 11301123
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/301123 | Protein formulation | Dec 11, 2005 | Issued |
Array
(
[id] => 5716086
[patent_doc_number] => 20060079449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Inhibition of Smad3 to prevent fibrosis and improve wound healing'
[patent_app_type] => utility
[patent_app_number] => 11/299122
[patent_app_country] => US
[patent_app_date] => 2005-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 21385
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20060079449.pdf
[firstpage_image] =>[orig_patent_app_number] => 11299122
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/299122 | Inhibition of Smad3 to prevent fibrosis and improve wound healing | Dec 8, 2005 | Abandoned |
Array
(
[id] => 418911
[patent_doc_number] => 07276583
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-02
[patent_title] => 'Modified Cry3A toxins'
[patent_app_type] => utility
[patent_app_number] => 11/294220
[patent_app_country] => US
[patent_app_date] => 2005-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19814
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/276/07276583.pdf
[firstpage_image] =>[orig_patent_app_number] => 11294220
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/294220 | Modified Cry3A toxins | Dec 4, 2005 | Issued |
Array
(
[id] => 4532583
[patent_doc_number] => 07888064
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-15
[patent_title] => 'Gram positive bacterial cells comprising a disrupted flagellin gene, flagellin-based fusion proteins and use in removal of metal ions from a liquid'
[patent_app_type] => utility
[patent_app_number] => 11/792242
[patent_app_country] => US
[patent_app_date] => 2005-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 34
[patent_no_of_words] => 22114
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/888/07888064.pdf
[firstpage_image] =>[orig_patent_app_number] => 11792242
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/792242 | Gram positive bacterial cells comprising a disrupted flagellin gene, flagellin-based fusion proteins and use in removal of metal ions from a liquid | Dec 1, 2005 | Issued |
Array
(
[id] => 6339831
[patent_doc_number] => 20100247509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'Fusion Proteins'
[patent_app_type] => utility
[patent_app_number] => 11/792210
[patent_app_country] => US
[patent_app_date] => 2005-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 22481
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20100247509.pdf
[firstpage_image] =>[orig_patent_app_number] => 11792210
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/792210 | Fusion proteins | Nov 30, 2005 | Issued |